We found that 2‐DG effectively decreased the expression of the pancreatic cancer stemness markers CD24 and CD133 (Fig. 3D) and reduced the levels of pluripotency markers Nanog and Sox2 in both protein and mRNA levels (Fig. 3E). The gene discussed is NANOG; the disease is pancreatic neoplasm.